Keywords: Diagnosis/Prediction, Diagnosis/Prediction
Motivation: HCC presents a significant treatment challenge due to varying patient responses to D-TACE. Current prediction methods often lack precision and rely on subjective assessments, limiting their effectiveness in personalized treatment planning
Goal(s): This study aimed to develop an accurate, automated prediction model for D-TACE efficacy by integrating multi-parametric MRI to enhance treatment outcome prediction
Approach: Using a deep learning framework, multi-parametric MRI features—arterial phase , diffusion-weighted imaging, and T2-weighted imaging—were combined to create a fusion model, capturing comprehensive tumor characteristics to improve predictive performance
Results: The fusion model achieved an AUC score of 0.829, outperforming single-sequence models and enhancing clinical decision-making for HCC patients
Impact: This model provides a non-invasive, reliable tool for predicting D-TACE outcomes, potentially transforming personalized treatment planning for HCC. Enhanced prediction accuracy can improve patient outcomes and optimize healthcare resources by tailoring treatment to individual needs
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords